Our results show significant benefits, notably in terms of relapse-free survival (RFS), as well as metastasis to bones and liver, with increased expression of both PSMB8 and PSMB9 by tumor cells, particularly in the context of basal-like breast cancer and TNBC. This evidence concerns the gene PSMB8 and breast carcinoma.